Regulatory Compliance & Dissolution Testing: What You Must Know
Executive Summary The Global Pharmaceutical Dissolution Testing Market is poised for transformative growth, surging from a valuation of USD 6.25 billion in 2022 to a projected USD 100.5 billion by 2032, advancing at a staggering compound annual growth rate (CAGR) of 30.5%. This rapid expansion is being driven by intensified pharmaceutical R&D activities, increasingly rigorous global regulatory frameworks, continuous technological advancements in analytical instruments, and the rising complexity of pharmaceutical formulations—particularly in the realm of personalized and modified-release drug delivery systems. Request Sample Report PDF (including TOC, Graphs & Tables): https://www.statsandresearch.com/request-sample/40467-global-pharmaceutical-dissolution-testing-market Market Overview Pharmaceutical dissolution testing is a cornerstone analytical technique employed throughout a drug’s lifecycle—from preclinical development to post-marketing surveillanc...